NF-kappaB activation is required for adaptive cardiac hypertrophy. (Q45924674)

From Wikidata

Jump to navigation Jump to search

scientific article published on 20 July 2009

edit

Language	Label	Description	Also known as
English	NF-kappaB activation is required for adaptive cardiac hypertrophy.	scientific article published on 20 July 2009

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19620128

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19620128

title

NF-kappaB activation is required for adaptive cardiac hypertrophy. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19620128

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19620128

main subject

NF-κB

0 references

author name string

Laura Zelarayan

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19620128

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19620128

Anke Renger

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19620128

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19620128

Claudia Noack

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19620128

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19620128

Maria-Patapia Zafiriou

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19620128

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19620128

Christina Gehrke

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19620128

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19620128

Roel van der Nagel

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19620128

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19620128

Rainer Dietz

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19620128

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19620128

Leon de Windt

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19620128

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19620128

Martin W Bergmann

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19620128

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19620128

publication date

20 July 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19620128

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19620128

published in

Cardiovascular Research

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19620128

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19620128

volume

84

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19620128

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19620128

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19620128

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19620128

page(s)

416-424

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19620128

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19620128

cites work

Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

retrieved

21 January 2018

The fuzzy logic of physiological cardiac hypertrophy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

retrieved

21 January 2018

Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

retrieved

21 January 2018

Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

retrieved

21 January 2018

Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension Study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

retrieved

21 January 2018

Gender differences in cardiac ACE expression are normalized in androgen-deprived male mice

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

retrieved

21 January 2018

Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

retrieved

21 January 2018

Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

retrieved

21 January 2018

Beta-catenin downregulation is required for adaptive cardiac remodeling

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

retrieved

21 January 2018

Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

retrieved

21 January 2018

Alterations in apoptosis regulatory factors during hypertrophy and heart failure

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

retrieved

21 January 2018

Abolition of end-organ damage by antiandrogen treatment in female hypertensive transgenic rats.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

retrieved

21 January 2018

Identifiers

DOI

10.1093/CVR/CVP237

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19620128

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19620128

PubMed publication ID

19620128

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19620128

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19620128

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45924674&oldid=815701348"